109 related articles for article (PubMed ID: 9070661)
1. Increase of spontaneous intrachromosomal homologous recombination in mammalian cells expressing a mutant p53 protein.
Bertrand P; Rouillard D; Boulet A; Levalois C; Soussi T; Lopez BS
Oncogene; 1997 Mar; 14(9):1117-22. PubMed ID: 9070661
[TBL] [Abstract][Full Text] [Related]
2. Dissociation of p53-mediated suppression of homologous recombination from G1/S cell cycle checkpoint control.
Willers H; McCarthy EE; Wu B; Wunsch H; Tang W; Taghian DG; Xia F; Powell SN
Oncogene; 2000 Feb; 19(5):632-9. PubMed ID: 10698508
[TBL] [Abstract][Full Text] [Related]
3. Homologous recombination induced by replication inhibition, is stimulated by expression of mutant p53.
Saintigny Y; Lopez BS
Oncogene; 2002 Jan; 21(3):488-92. PubMed ID: 11821962
[TBL] [Abstract][Full Text] [Related]
4. Generation of loss of heterozygosity and its dependency on p53 status in human lymphoblastoid cells.
Honma M
Environ Mol Mutagen; 2005; 45(2-3):162-76. PubMed ID: 15688360
[TBL] [Abstract][Full Text] [Related]
5. A novel host cell reactivation assay to assess homologous recombination capacity in human cancer cell lines.
Slebos RJ; Taylor JA
Biochem Biophys Res Commun; 2001 Feb; 281(1):212-9. PubMed ID: 11178982
[TBL] [Abstract][Full Text] [Related]
6. Mutant p53 proteins stimulate spontaneous and radiation-induced intrachromosomal homologous recombination independently of the alteration of the transactivation activity and of the G1 checkpoint.
Saintigny Y; Rouillard D; Chaput B; Soussi T; Lopez BS
Oncogene; 1999 Jun; 18(24):3553-63. PubMed ID: 10380877
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of mammalian Rad51 does not stimulate tumorigenesis while a dominant-negative Rad51 affects centrosome fragmentation, ploidy and stimulates tumorigenesis, in p53-defective CHO cells.
Bertrand P; Lambert S; Joubert C; Lopez BS
Oncogene; 2003 Oct; 22(48):7587-92. PubMed ID: 14576820
[TBL] [Abstract][Full Text] [Related]
8. Poly(ADP-ribose) polymerase-1 regulates the stability of the wild-type p53 protein.
Wesierska-Gadek J; Schmid G
Cell Mol Biol Lett; 2001; 6(2):117-40. PubMed ID: 11544635
[TBL] [Abstract][Full Text] [Related]
9. Functional interplay of p53 and Mus81 in DNA damage responses and cancer.
Pamidi A; Cardoso R; Hakem A; Matysiak-Zablocki E; Poonepalli A; Tamblyn L; Perez-Ordonez B; Hande MP; Sanchez O; Hakem R
Cancer Res; 2007 Sep; 67(18):8527-35. PubMed ID: 17875692
[TBL] [Abstract][Full Text] [Related]
10. Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations.
Delia D; Goi K; Mizutani S; Yamada T; Aiello A; Fontanella E; Lamorte G; Iwata S; Ishioka C; Krajewski S; Reed JC; Pierotti MA
Oncogene; 1997 May; 14(18):2137-47. PubMed ID: 9174049
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of p53 results in high rates of homologous recombination.
Mekeel KL; Tang W; Kachnic LA; Luo CM; DeFrank JS; Powell SN
Oncogene; 1997 Apr; 14(15):1847-57. PubMed ID: 9150391
[TBL] [Abstract][Full Text] [Related]
12. [p53 with a mutation in codon 273 increases the probability of amplifying the dhfr gene in Rat-1 and LIM1215 cells].
Il'inskaia GV; Pugacheva EN; Sokova OI; Chumakov PM; Kopnin BP
Genetika; 1995 May; 31(5):611-6. PubMed ID: 7622024
[TBL] [Abstract][Full Text] [Related]
13. Role of wild type p53 in the G2 phase: regulation of the gamma-irradiation-induced delay and DNA repair.
Schwartz D; Almog N; Peled A; Goldfinger N; Rotter V
Oncogene; 1997 Nov; 15(21):2597-607. PubMed ID: 9399647
[TBL] [Abstract][Full Text] [Related]
14. Involvement of human p53 in induced intrachromosomal recombination in Saccharomyces cerevisiae.
Del Carratore R; Petrucci A; Simili M; Fronza G; Galli A
Mutagenesis; 2004 Sep; 19(5):333-9. PubMed ID: 15388804
[TBL] [Abstract][Full Text] [Related]
15. Knock-in mice with a chimeric human/murine p53 gene develop normally and show wild-type p53 responses to DNA damaging agents: a new biomedical research tool.
Luo JL; Yang Q; Tong WM; Hergenhahn M; Wang ZQ; Hollstein M
Oncogene; 2001 Jan; 20(3):320-8. PubMed ID: 11313961
[TBL] [Abstract][Full Text] [Related]
16. Wild-type p53 inhibits replication-associated homologous recombination.
Janz C; Wiesmüller L
Oncogene; 2002 Aug; 21(38):5929-33. PubMed ID: 12185593
[TBL] [Abstract][Full Text] [Related]
17. Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function.
de Vries A; Flores ER; Miranda B; Hsieh HM; van Oostrom CT; Sage J; Jacks T
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2948-53. PubMed ID: 11867759
[TBL] [Abstract][Full Text] [Related]
18. Role of p53 mutations, protein function and DNA damage for the radiosensitivity of human tumour cells.
Böhnke A; Westphal F; Schmidt A; El-Awady RA; Dahm-Daphi J
Int J Radiat Biol; 2004 Jan; 80(1):53-63. PubMed ID: 14761850
[TBL] [Abstract][Full Text] [Related]
19. BRCA2 regulates homologous recombination in response to DNA damage: implications for genome stability and carcinogenesis.
Abaji C; Cousineau I; Belmaaza A
Cancer Res; 2005 May; 65(10):4117-25. PubMed ID: 15899802
[TBL] [Abstract][Full Text] [Related]
20. The role of p53-mediated apoptosis as a crucial anti-tumor response to genomic instability: lessons from mouse models.
Attardi LD
Mutat Res; 2005 Jan; 569(1-2):145-57. PubMed ID: 15603759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
